Association between serum fibroblast growth factor‐23 concentration and development of hyperphosphatemia in normophosphatemic dogs with chronic kidney disease

BACKGROUND: Fibroblast growth factor (FGF)‐23 is increased first in the sequence of changes associated with chronic kidney disease (CKD)‐mineral and bone disorder. Thus, its measurement may serve as a predictive indicator of incident hyperphosphatemia. OBJECTIVES: To investigate whether serum FGF‐23...

Descripción completa

Detalles Bibliográficos
Autores principales: Miyakawa, Hirosumi, Hsu, Huai‐Hsun, Ogawa, Mizuki, Akabane, Ryota, Miyagawa, Yuichi, Takemura, Naoyuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2021
Materias:
SMALL ANIMAL
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8478064/
https://www.ncbi.nlm.nih.gov/pubmed/34418162
http://dx.doi.org/10.1111/jvim.16237

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8478064/
https://www.ncbi.nlm.nih.gov/pubmed/34418162
http://dx.doi.org/10.1111/jvim.16237

Ejemplares similares